Summary
Definition
History and exam
Key diagnostic factors
- history of pituitary/hypothalamic disease
- family history/genetic mutations
- history of lithium therapy (or certain other drugs)
- history of autoimmune disorders
- polyuria
- increased thirst/polydipsia
Other diagnostic factors
- nocturia
- signs of volume depletion
- non-specific central nervous system symptoms of hypernatraemia
- visual field defects
- endocrine signs
- focal motor deficits
- sensorineural deafness and visual failure
- skin lesions
Risk factors
- pituitary surgery
- craniopharyngioma
- pituitary stalk lesions
- traumatic brain injury
- congenital pituitary abnormalities
- use of certain drugs
- hypophysitis
- autoimmune disease
- family history/genetic mutations
- pregnancy
- subarachnoid haemorrhage
- renal sarcoidosis
- renal amyloidosis
- hypercalcaemia or hypokalaemia
- release of obstructive uropathy
- previous central nervous system infections
Diagnostic investigations
1st investigations to order
- urine osmolality
- serum osmolality
- serum glucose
- serum sodium
- serum potassium
- serum urea nitrogen
- serum calcium
- urine dipstick
- 24-hour urine collection for volume
- water deprivation test
- AVP (desmopressin) stimulation test
- hypertonic saline-stimulated test with measurement of copeptin
Investigations to consider
- pituitary MRI (contrast-enhanced)
- genetic testing
- antithyroid peroxidase autoantibodies
- serum and cerebrospinal fluid alpha-fetoprotein and beta-human chorionic gonadotrophin
- serum growth hormone (GH)
- serum insulin-like growth factor 1 (IGF-1)
- provocative growth hormone (GH) tests
- serum LH
- serum follicle-stimulating hormone
- morning serum testosterone
- serum thyroid-stimulating hormone and triiodothyronine/thyroxine (T3/T4)
- morning serum cortisol and adrenocorticotrophic hormone (ACTH)
- tetracosactide stimulation test
- serum prolactin
Treatment algorithm
hypernatraemia at any stage
acute arginine vasopressin deficiency (AVP-D)
chronic arginine vasopressin deficiency (AVP-D)
arginine vasopressin resistance (AVP-R)
Contributors
Authors
Miles Levy MBBS, MD, FRCP,
Consultant Endocrinologist
University Hospitals of Leicester
Hon. Associate Professor at Leicester University
Leicester
UK
Disclosures
Mark Sherlock MB, MRCPI, MD, PhD,
Consultant Endocrinologist
Beaumont Hospital
Professor of Medicine
Royal College of Surgeons in Ireland
Dublin
Ireland
Disclosures
MS has received consultancy fees for Ferring (manufacturers of desmopressin).
Acknowledgements
Professor Miles Levy and Professor Mark Sherlock wish to gratefully acknowledge Professor Stephen Ball, a previous contributor to this topic.
Disclosures
SB declares that he has no competing interests.
Peer reviewers
Janet Amico, MD
Professor of Medicine
Division of Endocrinology and Metabolism
University of Pittsburgh School of Medicine
Pittsburgh
PA
Disclosures
At the time of peer review, JA received research grants from the National Institutes of Health, the Department of Veterans' Affairs, and the Department of Defense. We were made aware that Professor Amico is now deceased.
Differentials
- Psychogenic polydipsia
- Diabetes mellitus
- Diuretic use
More DifferentialsGuidelines
- Diabetes insipidus
- Inpatient management of cranial diabetes insipidus
More GuidelinesPatient information
Diabetes insipidus
More Patient informationCalculators
Osmolality Estimator (serum)
More CalculatorsLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer